|
|
||||||||
Division of Cardiovascular and Thoracic Surgery, Duke University Medical Center, Box 3340, Durham, NC 27710
(Email: andrew.lodge@duke.edu).
| The first 20% of the full text of this article appears below. |
The use of left ventricular assist devices (LVADs) has become routine practice at many centers around the United States and abroad. This therapy has evolved fairly quickly and the development of new devices has outpaced the regulatory machinery that governs their use. Since the United States Food and Drug Administration approval of the Thoratec Heartmate XVE (Thoratec Corporation, Pleasanton, CA) for destination therapy, there has yet to be another device approved for this purpose. For this reason, as well as the fact that this device remains the
Related Article
Ann. Thorac. Surg. 2008 85: 1646-1649.
This article has been cited by other articles:
![]() |
Y. J. Woo and M. A. Acker Implantable Ventricular Assist Device Exchange With Focused Intravascular Deairing Techniques Ann. Thorac. Surg., January 1, 2011; 91(1): 306 - 307. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |